Also, the expression of HNF1β, Napsin A, and AMACR markers was reported in 101 cases of serous carcinoma 7%, 1%, and 1% and in endometrioid carcinoma 37%, 5.3%, and 0%. This evidence concerns the gene AMACR and serous adenocarcinoma.